<?xml version="1.0" encoding="UTF-8"?>
<corpus source="DS1">
    <document id="DS1.d0" origId="17003041">
        <sentence id="DS1.d0.s0" origId="17003041-308" text="Bestrophin-1  enables Ca2+-activated Cl-conductance in epithelia.">
            <entity id="DS1.d0.s0.e0" origId="O76090,O88870,Q21973,Q6UY87,Q8WMR7" charOffset="0-12" type="protein" text="Bestrophin-1"/>
            <entity id="DS1.d0.s0.e1" origId="312" charOffset="37-39" type="compound" text="Cl"/>
            <pair e1="DS1.d0.s0.e1" e2="DS1.d0.s0.e0" id="DS1.d0.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d1" origId="17321121">
        <sentence id="DS1.d1.s0" origId="17321121-703" text="The absorption spectrum of the hydrogenase enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-sulfur clusters.">
            <entity id="DS1.d1.s0.e0" origId="P80509,P80510" charOffset="31-42" type="protein" text="hydrogenase"/>
            <entity id="DS1.d1.s0.e1" origId="402" charOffset="121-127" type="compound" text="sulfur"/>
            <pair e1="DS1.d1.s0.e1" e2="DS1.d1.s0.e0" id="DS1.d1.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d2" origId="17403602">
        <sentence id="DS1.d2.s0" origId="17403602-1073" text="When Vitreoscilla were grown in medium containing 60mM sodium nitrite under both normal and limited aeration conditions, the levels of Vitreoscilla hemoglobin (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.">
            <entity id="DS1.d2.s0.e0" origId="23668193" charOffset="55-69" type="compound" text="sodium nitrite"/>
            <entity id="DS1.d2.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="148-158" type="protein" text="hemoglobin"/>
            <pair e1="DS1.d2.s0.e0" e2="DS1.d2.s0.e1" id="DS1.d2.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d3" origId="17449233">
        <sentence id="DS1.d3.s0" origId="17449233-170" text="The wild-type exposed to low pH tremendously reduced IL-8  level at early phase, but restored with urea, suggesting that low pH exerted the kinetics of H. pylori-induced IL-8 production in CagA-dependent manner and urea was necessary for effective induction.">
            <entity id="DS1.d3.s0.e0" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="53-57" type="protein" text="IL-8"/>
            <entity id="DS1.d3.s0.e1" origId="1176,265993" charOffset="99-103" type="compound" text="urea"/>
            <entity id="DS1.d3.s0.e2" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="170-174" type="protein" text="IL-8"/>
            <entity id="DS1.d3.s0.e3" origId="P55746,P55980,P80200,Q06110,Q9ZLT1" charOffset="189-193" type="protein" text="CagA"/>
            <entity id="DS1.d3.s0.e4" origId="1176,265993" charOffset="215-219" type="compound" text="urea"/>
            <pair e1="DS1.d3.s0.e1" e2="DS1.d3.s0.e0" id="DS1.d3.s0.i0" interaction="True" />
            <pair e1="DS1.d3.s0.e1" e2="DS1.d3.s0.e3" id="DS1.d3.s0.i1" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d4" origId="17590240">
        <sentence id="DS1.d4.s0" origId="17590240-1233" text="Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation.">
            <entity id="DS1.d4.s0.e0" origId="65064" charOffset="0-30" type="compound" text="Epigallocatechin gallate (EGCG"/>
            <entity id="DS1.d4.s0.e1" origId="P00520,P00522" charOffset="99-102" type="protein" text="Abl"/>
            <entity id="DS1.d4.s0.e2" origId="O00213" charOffset="103-107" type="protein" text="FE65"/>
            <entity id="DS1.d4.s0.e3" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="134-143" type="protein" text="GSK3 beta"/>
            <pair e1="DS1.d4.s0.e0" e2="DS1.d4.s0.e3" id="DS1.d4.s0.i0" interaction="True" />
            <pair e1="DS1.d4.s0.e0" e2="DS1.d4.s0.e1" id="DS1.d4.s0.i1" interaction="True" />
            <pair e1="DS1.d4.s0.e0" e2="DS1.d4.s0.e2" id="DS1.d4.s0.i2" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d5" origId="17616381">
        <sentence id="DS1.d5.s0" origId="17616381-939" text="The protease was purified to homogeneity using  ammonium  sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.">
            <entity id="DS1.d5.s0.e0" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="4-12" type="protein" text="protease"/>
            <entity id="DS1.d5.s0.e1" origId="223" charOffset="48-56" type="compound" text="ammonium"/>
            <entity id="DS1.d5.s0.e2" origId="1117" charOffset="58-65" type="compound" text="sulfate"/>
            <pair e1="DS1.d5.s0.e2" e2="DS1.d5.s0.e0" id="DS1.d5.s0.i0" interaction="True" />
            <pair e1="DS1.d5.s0.e1" e2="DS1.d5.s0.e0" id="DS1.d5.s0.i1" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d6" origId="17629591">
        <sentence id="DS1.d6.s0" origId="17629591-232" text="In addition, we demonstrated that Hsp20, HspB2 and HspB8  induced  interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by dexamethasone, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.">
            <entity id="DS1.d6.s0.e0" origId="O35878,Q16082,Q99PR8" charOffset="41-46" type="protein" text="HspB2"/>
            <entity id="DS1.d6.s0.e1" origId="Q5EAC9,Q5RAB0,Q6SJQ8,Q8MJ36,Q9EPX0,Q9JK92,Q9UJY1" charOffset="51-56" type="protein" text="HspB8"/>
            <entity id="DS1.d6.s0.e2" origId="P41693" charOffset="67-80" type="protein" text="interleukin-6"/>
            <entity id="DS1.d6.s0.e3" origId="5743" charOffset="160-173" type="compound" text="dexamethasone"/>
            <pair e1="DS1.d6.s0.e3" e2="DS1.d6.s0.e0" id="DS1.d6.s0.i0" interaction="True" />
            <pair e1="DS1.d6.s0.e3" e2="DS1.d6.s0.e2" id="DS1.d6.s0.i1" interaction="True" />
            <pair e1="DS1.d6.s0.e3" e2="DS1.d6.s0.e1" id="DS1.d6.s0.i2" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d7" origId="17692997">
        <sentence id="DS1.d7.s0" origId="17692997-196" text="Furthermore, dithiothreitol was found to be capable of significantly preventing the inhibitory effect of insulin on Abeta oligomer formation.">
            <entity id="DS1.d7.s0.e0" origId="19001,439196,446094" charOffset="13-27" type="compound" text="dithiothreitol"/>
            <entity id="DS1.d7.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="105-112" type="protein" text="insulin"/>
            <pair e1="DS1.d7.s0.e0" e2="DS1.d7.s0.e1" id="DS1.d7.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d8" origId="17719144">
        <sentence id="DS1.d8.s0" origId="17719144-1177" text="The scavenger receptor, class B, type I (SR-BI) is critical in maintaining the homeostasis of cholesterol and alpha-tocopherol.">
            <entity id="DS1.d8.s0.e0" origId="P21988,P21989,P21990,P21991,P21992" charOffset="24-31" type="protein" text="class B"/>
            <entity id="DS1.d8.s0.e1" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="41-46" type="protein" text="SR-BI"/>
            <entity id="DS1.d8.s0.e2" origId="304,5997,6432564,11025495" charOffset="94-105" type="compound" text="cholesterol"/>
            <entity id="DS1.d8.s0.e3" origId="2116,14985" charOffset="110-126" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS1.d8.s0.e3" e2="DS1.d8.s0.e0" id="DS1.d8.s0.i0" interaction="True" />
            <pair e1="DS1.d8.s0.e3" e2="DS1.d8.s0.e1" id="DS1.d8.s0.i1" interaction="True" />
            <pair e1="DS1.d8.s0.e2" e2="DS1.d8.s0.e1" id="DS1.d8.s0.i2" interaction="True" />
            <pair e1="DS1.d8.s0.e2" e2="DS1.d8.s0.e0" id="DS1.d8.s0.i3" interaction="True" />
        </sentence>
        <sentence id="DS1.d8.s1" origId="17719144-1178" text="SR-BI  binds  high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and alpha-tocopherol from circulating HDL to cells.">
            <entity id="DS1.d8.s1.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="0-5" type="protein" text="SR-BI"/>
            <entity id="DS1.d8.s1.e1" origId="P81182" charOffset="14-39" type="protein" text="high-density lipoproteins"/>
            <entity id="DS1.d8.s1.e2" origId="2116,14985" charOffset="108-124" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS1.d8.s1.e2" e2="DS1.d8.s1.e1" id="DS1.d8.s1.i0" interaction="True" />
            <pair e1="DS1.d8.s1.e2" e2="DS1.d8.s1.e0" id="DS1.d8.s1.i1" interaction="True" />
        </sentence>
        <sentence id="DS1.d8.s2" origId="17719144-1179" text="Thus, SR-BI  influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and alpha-tocopherol  homeostasis in proper cognitive function.">
            <entity id="DS1.d8.s2.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="6-11" type="protein" text="SR-BI"/>
            <entity id="DS1.d8.s2.e1" origId="304,5997,6432564,11025495" charOffset="102-113" type="compound" text="cholesterol"/>
            <entity id="DS1.d8.s2.e2" origId="2116,14985" charOffset="118-134" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS1.d8.s2.e1" e2="DS1.d8.s2.e0" id="DS1.d8.s2.i0" interaction="False" />
            <pair e1="DS1.d8.s2.e2" e2="DS1.d8.s2.e0" id="DS1.d8.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS1.d9" origId="17768029">
        <sentence id="DS1.d9.s0" origId="17768029-989" text="Our data show that these mice possess hyperglycemia, hypoinsulinism and morphological characteristics of impaired pancreas that are consistent with the accepted diabetogenic effects of alloxan. Alloxan is believed to confer its diabetogenic effect by inhibiting pancreatic glucokinase activity, leading to pancreatic beta-cell death.">
            <entity id="DS1.d9.s0.e0" origId="5781" charOffset="185-192" type="compound" text="alloxan"/>
            <entity id="DS1.d9.s0.e1" origId="5781" charOffset="194-201" type="compound" text="Alloxan"/>
            <entity id="DS1.d9.s0.e2" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="273-284" type="protein" text="glucokinase"/>
            <pair e1="DS1.d9.s0.e2" e2="DS1.d9.s0.e2" id="DS1.d9.s0.i0" interaction="True" />
            <pair e1="DS1.d9.s0.e2" e2="DS1.d9.s0.e2" id="DS1.d9.s0.i1" interaction="True" />
        </sentence>
        <sentence id="DS1.d9.s1" origId="17768029-990" text="Given the important role of glucokinase as a glucose sensor, and our findings on the effects of alloxon on liver glucokinase activity we propose that the effects on the liver are the primary contributor to pathogenesis in alloxan-induced diabetes. Alloxan-induced diabetes is thus a multifactor-promoted diabetes model which still could be used to examine the antidiabetic effects of compounds prompting  insulin  secretion and increasing liver-specific glucokinase activity.">
            <entity id="DS1.d9.s1.e0" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="28-39" type="protein" text="glucokinase"/>
            <entity id="DS1.d9.s1.e1" origId="206,5793,64689,79025" charOffset="45-52" type="compound" text="glucose"/>
            <entity id="DS1.d9.s1.e2" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="113-124" type="protein" text="glucokinase"/>
            <entity id="DS1.d9.s1.e3" origId="5781" charOffset="222-229" type="compound" text="alloxan"/>
            <entity id="DS1.d9.s1.e4" origId="5781" charOffset="248-255" type="compound" text="Alloxan"/>
            <entity id="DS1.d9.s1.e5" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="405-412" type="protein" text="insulin"/>
            <entity id="DS1.d9.s1.e6" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="113-124" type="protein" text="glucokinase"/>
            <pair e1="DS1.d9.s1.e1" e2="DS1.d9.s1.e5" id="DS1.d9.s1.i0" interaction="True" />
            <pair e1="DS1.d9.s1.e1" e2="DS1.d9.s1.e0" id="DS1.d9.s1.i1" interaction="True" />
            <pair e1="DS1.d9.s1.e6" e2="DS1.d9.s1.e5" id="DS1.d9.s1.i2" interaction="True" />
            <pair e1="DS1.d9.s1.e6" e2="DS1.d9.s1.e0" id="DS1.d9.s1.i3" interaction="True" />
            <pair e1="DS1.d9.s1.e6" e2="DS1.d9.s1.e5" id="DS1.d9.s1.i4" interaction="True" />
            <pair e1="DS1.d9.s1.e6" e2="DS1.d9.s1.e0" id="DS1.d9.s1.i5" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d10" origId="17882129">
        <sentence id="DS1.d10.s0" origId="17882129-606" text="Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals.">
            <entity id="DS1.d10.s0.e0" origId="2116,14985" charOffset="0-16" type="compound" text="Alpha-tocopherol"/>
            <entity id="DS1.d10.s0.e1" origId="P22862" charOffset="96-108" type="protein" text="arylesterase"/>
            <pair e1="DS1.d10.s0.e0" e2="DS1.d10.s0.e1" id="DS1.d10.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d11" origId="17888544">
        <sentence id="DS1.d11.s0" origId="17888544-783" text="Although ApoE4 has been repeatedly associated with altered sphingomyelin and cholesterol levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.">
            <entity id="DS1.d11.s0.e0" origId="304,5997,6432564,11025495" charOffset="77-88" type="compound" text="cholesterol"/>
            <entity id="DS1.d11.s0.e1" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="9-13" type="protein" text="ApoE"/>
            <pair e1="DS1.d11.s0.e0" e2="DS1.d11.s0.e1" id="DS1.d11.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS1.d12" origId="17888546">
        <sentence id="DS1.d12.s0" origId="17888546-784" text="In this prospective study we examined whether total cholesterol and the oxysterols 24S- and 27-hydroxycholesterol were related to cognitive performance and rate of cognitive decline in elderly, and whether these associations were modified by ApoE  epsilon 4.">
            <entity id="DS1.d12.s0.e0" origId="304,5997,6432564,11025495" charOffset="52-63" type="compound" text="cholesterol"/>
            <entity id="DS1.d12.s0.e1" origId="50919265" charOffset="83-86" type="compound" text="24S"/>
            <entity id="DS1.d12.s0.e2" origId="99470,123976,50990021" charOffset="92-113" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS1.d12.s0.e3" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="242-246" type="protein" text="ApoE"/>
            <entity id="DS1.d12.s0.e4" origId="P05463" charOffset="248-255" type="protein" text="epsilon"/>
            <pair e1="DS1.d12.s0.e1" e2="DS1.d12.s0.e3" id="DS1.d12.s0.i0" interaction="True" />
            <pair e1="DS1.d12.s0.e2" e2="DS1.d12.s0.e4" id="DS1.d12.s0.i1" interaction="True" />
            <pair e1="DS1.d12.s0.e2" e2="DS1.d12.s0.e3" id="DS1.d12.s0.i2" interaction="True" />
            <pair e1="DS1.d12.s0.e0" e2="DS1.d12.s0.e3" id="DS1.d12.s0.i3" interaction="True" />
            <pair e1="DS1.d12.s0.e1" e2="DS1.d12.s0.e4" id="DS1.d12.s0.i4" interaction="True" />
            <pair e1="DS1.d12.s0.e0" e2="DS1.d12.s0.e4" id="DS1.d12.s0.i5" interaction="True" />
        </sentence>
        <sentence id="DS1.d12.s1" origId="17888546-785" text="ApoE  modified the association between cholesterol and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.">
            <entity id="DS1.d12.s1.e0" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="0-4" type="protein" text="ApoE"/>
            <entity id="DS1.d12.s1.e1" origId="304,5997,6432564,11025495" charOffset="39-50" type="compound" text="cholesterol"/>
            <entity id="DS1.d12.s1.e2" origId="99470,123976,50990021" charOffset="115-136" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS1.d12.s1.e3" origId="304,5997,6432564,11025495" charOffset="125-136" type="compound" text="cholesterol"/>
            <pair e1="DS1.d12.s1.e2" e2="DS1.d12.s1.e0" id="DS1.d12.s1.i0" interaction="True" />
            <pair e1="DS1.d12.s1.e1" e2="DS1.d12.s1.e0" id="DS1.d12.s1.i1" interaction="True" />
        </sentence>
        <sentence id="DS1.d12.s2" origId="17888546-786" text="In ApoE  epsilon 4 carriers, lower  cholesterol was related to a higher rate of decline on information processing speed (p=.006), and a higher ratio of 27-hydroxycholesterol to cholesterol was related to a lower level of general performance (p=.002) and memory functioning (p=.045).">
            <entity id="DS1.d12.s2.e0" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="3-7" type="protein" text="ApoE"/>
            <entity id="DS1.d12.s2.e1" origId="P05463" charOffset="9-16" type="protein" text="epsilon"/>
            <entity id="DS1.d12.s2.e2" origId="304,5997,6432564,11025495" charOffset="36-47" type="compound" text="cholesterol"/>
            <entity id="DS1.d12.s2.e3" origId="99470,123976,50990021" charOffset="152-173" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS1.d12.s2.e4" origId="304,5997,6432564,11025495" charOffset="162-173" type="compound" text="cholesterol"/>
            <pair e1="DS1.d12.s2.e3" e2="DS1.d12.s2.e0" id="DS1.d12.s2.i0" interaction="True" />
            <pair e1="DS1.d12.s2.e3" e2="DS1.d12.s2.e1" id="DS1.d12.s2.i1" interaction="True" />
            <pair e1="DS1.d12.s2.e2" e2="DS1.d12.s2.e0" id="DS1.d12.s2.i2" interaction="True" />
            <pair e1="DS1.d12.s2.e2" e2="DS1.d12.s2.e1" id="DS1.d12.s2.i3" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d13" origId="17890844">
        <sentence id="DS1.d13.s0" origId="17890844-956" text="Here we show that during growth in media containing glucose and in complex medium without glucose RamB activates expression of the aceE gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.">
            <entity id="DS1.d13.s0.e0" origId="206,5793,64689,79025" charOffset="52-59" type="compound" text="glucose"/>
            <entity id="DS1.d13.s0.e1" origId="206,5793,64689,79025" charOffset="90-97" type="compound" text="glucose"/>
            <entity id="DS1.d13.s0.e2" origId="P0AFG8,P0AFG9,P45119,P57301,Q10504,Q59637,Q89AR0,Q8K9T9" charOffset="131-135" type="protein" text="aceE"/>
            <pair e1="DS1.d13.s0.e0" e2="DS1.d13.s0.e2" id="DS1.d13.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d14" origId="17895513">
        <sentence id="DS1.d14.s0" origId="17895513-61" text="We studied the effects of unfractionated heparin (UFH) versus low-molecular-weight heparin (LMWH), enoxaparin, used as anticoagulants during hemodialysis (HD) on plasma levels of circulating endothelium-derived molecules: thrombomodulin (TM), von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1), cell surface adhesion molecules (E-selectin), intercellular adhesion molecule-1 (ICAM-1), and prothrombin fragment 1+2 (PF 1+2).">
            <entity id="DS1.d14.s0.e0" origId="772" charOffset="92-96" type="compound" text="LMWH"/>
            <entity id="DS1.d14.s0.e1" origId="P06579" charOffset="222-236" type="protein" text="thrombomodulin"/>
            <entity id="DS1.d14.s0.e2" origId="Q62935" charOffset="243-264" type="protein" text="von Willebrand factor"/>
            <entity id="DS1.d14.s0.e3" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="266-269" type="protein" text="vWF"/>
            <entity id="DS1.d14.s0.e4" origId="4929" charOffset="350-358" type="compound" text="selectin"/>
            <entity id="DS1.d14.s0.e5" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="396-402" type="protein" text="ICAM-1"/>
            <entity id="DS1.d14.s0.e6" origId="P51524" charOffset="435-439" type="protein" text="PF 1"/>
            <pair e1="DS1.d14.s0.e4" e2="DS1.d14.s0.e6" id="DS1.d14.s0.i0" interaction="True" />
            <pair e1="DS1.d14.s0.e4" e2="DS1.d14.s0.e3" id="DS1.d14.s0.i1" interaction="True" />
            <pair e1="DS1.d14.s0.e4" e2="DS1.d14.s0.e2" id="DS1.d14.s0.i2" interaction="True" />
            <pair e1="DS1.d14.s0.e0" e2="DS1.d14.s0.e6" id="DS1.d14.s0.i3" interaction="True" />
            <pair e1="DS1.d14.s0.e0" e2="DS1.d14.s0.e2" id="DS1.d14.s0.i4" interaction="True" />
            <pair e1="DS1.d14.s0.e0" e2="DS1.d14.s0.e3" id="DS1.d14.s0.i5" interaction="True" />
            <pair e1="DS1.d14.s0.e4" e2="DS1.d14.s0.e5" id="DS1.d14.s0.i6" interaction="True" />
            <pair e1="DS1.d14.s0.e0" e2="DS1.d14.s0.e1" id="DS1.d14.s0.i7" interaction="True" />
            <pair e1="DS1.d14.s0.e0" e2="DS1.d14.s0.e5" id="DS1.d14.s0.i8" interaction="True" />
            <pair e1="DS1.d14.s0.e4" e2="DS1.d14.s0.e1" id="DS1.d14.s0.i9" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d15" origId="17904221">
        <sentence id="DS1.d15.s0" origId="17904221-347" text="Therefore, we decided to investigate homovanillic (HVA) and prolactin (PRL) plasma levels, as expression of possible changes in dopamine function, ACTH and cortisol plasma levels, as measures of HPA axis function, and concomitant psychiatric symptoms profile in abstinent cocaine addicts, in relationship to their childhood history of neglect and poor parental care perception.">
            <entity id="DS1.d15.s0.e0" origId="1738" charOffset="51-54" type="compound" text="HVA"/>
            <entity id="DS1.d15.s0.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="60-69" type="protein" text="prolactin"/>
            <entity id="DS1.d15.s0.e2" origId="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6" charOffset="71-74" type="protein" text="PRL"/>
            <entity id="DS1.d15.s0.e3" origId="681" charOffset="128-136" type="compound" text="dopamine"/>
            <entity id="DS1.d15.s0.e4" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="147-151" type="protein" text="ACTH"/>
            <entity id="DS1.d15.s0.e5" origId="5754" charOffset="156-164" type="compound" text="cortisol"/>
            <entity id="DS1.d15.s0.e6" origId="2826,5760,439497,446220,644017,54613779" charOffset="272-279" type="compound" text="cocaine"/>
            <pair e1="DS1.d15.s0.e3" e2="DS1.d15.s0.e4" id="DS1.d15.s0.i0" interaction="True" />
            <pair e1="DS1.d15.s0.e6" e2="DS1.d15.s0.e4" id="DS1.d15.s0.i1" interaction="False" />
            <pair e1="DS1.d15.s0.e3" e2="DS1.d15.s0.e1" id="DS1.d15.s0.i2" interaction="True" />
            <pair e1="DS1.d15.s0.e0" e2="DS1.d15.s0.e1" id="DS1.d15.s0.i3" interaction="True" />
            <pair e1="DS1.d15.s0.e5" e2="DS1.d15.s0.e1" id="DS1.d15.s0.i4" interaction="True" />
            <pair e1="DS1.d15.s0.e3" e2="DS1.d15.s0.e2" id="DS1.d15.s0.i5" interaction="True" />
            <pair e1="DS1.d15.s0.e0" e2="DS1.d15.s0.e4" id="DS1.d15.s0.i6" interaction="True" />
            <pair e1="DS1.d15.s0.e0" e2="DS1.d15.s0.e2" id="DS1.d15.s0.i7" interaction="True" />
            <pair e1="DS1.d15.s0.e5" e2="DS1.d15.s0.e2" id="DS1.d15.s0.i8" interaction="True" />
            <pair e1="DS1.d15.s0.e6" e2="DS1.d15.s0.e2" id="DS1.d15.s0.i9" interaction="False" />
            <pair e1="DS1.d15.s0.e5" e2="DS1.d15.s0.e4" id="DS1.d15.s0.i10" interaction="True" />
            <pair e1="DS1.d15.s0.e6" e2="DS1.d15.s0.e1" id="DS1.d15.s0.i11" interaction="False" />
        </sentence>
    </document>
    <document id="DS1.d16" origId="17925795">
        <sentence id="DS1.d16.s0" origId="17925795-1044" text="The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.">
            <entity id="DS1.d16.s0.e0" origId="28486,3028194" charOffset="21-28" type="compound" text="lithium"/>
            <entity id="DS1.d16.s0.e1" origId="3121" charOffset="33-42" type="compound" text="valproate"/>
            <entity id="DS1.d16.s0.e2" origId="P25430,P25431,P25432,Q06225" charOffset="83-116" type="protein" text="brain-derived neurotrophic factor"/>
            <pair e1="DS1.d16.s0.e0" e2="DS1.d16.s0.e2" id="DS1.d16.s0.i0" interaction="True" />
            <pair e1="DS1.d16.s0.e1" e2="DS1.d16.s0.e2" id="DS1.d16.s0.i1" interaction="True" />
        </sentence>
        <sentence id="DS1.d16.s1" origId="17925795-1045" text="Treatment of cultured rat cortical neurons with therapeutic concentrations of LiCl or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing BDNF mRNA, and the activity of BDNF promoter IV.">
            <entity id="DS1.d16.s1.e0" origId="433294" charOffset="78-82" type="compound" text="LiCl"/>
            <entity id="DS1.d16.s1.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="169-173" type="protein" text="BDNF"/>
            <entity id="DS1.d16.s1.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="200-204" type="protein" text="BDNF"/>
            <pair e1="DS1.d16.s1.e0" e2="DS1.d16.s1.e1" id="DS1.d16.s1.i0" interaction="True" />
        </sentence>
        <sentence id="DS1.d16.s2" origId="17925795-1046" text="We showed that lithium-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.">
            <entity id="DS1.d16.s2.e0" origId="28486,3028194" charOffset="15-22" type="compound" text="lithium"/>
            <entity id="DS1.d16.s2.e1" origId="P51136,P83101" charOffset="103-108" type="protein" text="GSK-3"/>
            <entity id="DS1.d16.s2.e2" origId="P18265,P49840" charOffset="169-179" type="protein" text="GSK-3alpha"/>
            <entity id="DS1.d16.s2.e3" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="183-192" type="protein" text="GSK-3beta"/>
            <pair e1="DS1.d16.s2.e0" e2="DS1.d16.s2.e3" id="DS1.d16.s2.i0" interaction="False" />
            <pair e1="DS1.d16.s2.e0" e2="DS1.d16.s2.e1" id="DS1.d16.s2.i1" interaction="False" />
            <pair e1="DS1.d16.s2.e0" e2="DS1.d16.s2.e2" id="DS1.d16.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS1.d16.s3" origId="17925795-1047" text="Furthermore, treatment with other HDAC inhibitors, sodium butyrate and trichostatin A, or transfection with an HDAC1-specific siRNA also activated  BDNF promoter IV.">
            <entity id="DS1.d16.s3.e0" origId="264" charOffset="51-66" type="compound" text="sodium butyrate"/>
            <entity id="DS1.d16.s3.e1" origId="444732" charOffset="71-85" type="compound" text="trichostatin A"/>
            <entity id="DS1.d16.s3.e2" origId="P56517,P56518,Q13547,Q94517" charOffset="111-116" type="protein" text="HDAC1"/>
            <entity id="DS1.d16.s3.e3" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="148-152" type="protein" text="BDNF"/>
            <pair e1="DS1.d16.s3.e0" e2="DS1.d16.s3.e3" id="DS1.d16.s3.i0" interaction="False" />
            <pair e1="DS1.d16.s3.e1" e2="DS1.d16.s3.e3" id="DS1.d16.s3.i1" interaction="False" />
            <pair e1="DS1.d16.s3.e1" e2="DS1.d16.s3.e2" id="DS1.d16.s3.i2" interaction="False" />
            <pair e1="DS1.d16.s3.e0" e2="DS1.d16.s3.e2" id="DS1.d16.s3.i3" interaction="False" />
        </sentence>
        <sentence id="DS1.d16.s4" origId="17925795-1048" text="Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for lithium and VPA to activate  BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.">
            <entity id="DS1.d16.s4.e0" origId="P51136,P83101" charOffset="47-52" type="protein" text="GSK-3"/>
            <entity id="DS1.d16.s4.e1" origId="28486,3028194" charOffset="97-104" type="compound" text="lithium"/>
            <entity id="DS1.d16.s4.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="126-130" type="protein" text="BDNF"/>
            <entity id="DS1.d16.s4.e3" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="158-162" type="protein" text="BDNF"/>
            <entity id="DS1.d16.s4.e4" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="158-162" type="protein" text="BDNF"/>
            <pair e1="DS1.d16.s4.e1" e2="DS1.d16.s4.e2" id="DS1.d16.s4.i0" interaction="True" />
            <pair e1="DS1.d16.s4.e1" e2="DS1.d16.s4.e0" id="DS1.d16.s4.i1" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d17" origId="17943458">
        <sentence id="DS1.d17.s0" origId="17943458-547" text="N-acetylaspartic acid (NAA) is converted into aspartate and acetate by aspartoacylase.">
            <entity id="DS1.d17.s0.e0" origId="65065" charOffset="0-21" type="compound" text="N-acetylaspartic acid"/>
            <entity id="DS1.d17.s0.e1" origId="5960" charOffset="46-55" type="compound" text="aspartate"/>
            <entity id="DS1.d17.s0.e2" origId="53627460" charOffset="60-67" type="compound" text="acetate"/>
            <entity id="DS1.d17.s0.e3" origId="P45381,P46446,Q60HH2,Q8R3P0,Q9R1T5" charOffset="71-85" type="protein" text="aspartoacylase"/>
            <pair e1="DS1.d17.s0.e0" e2="DS1.d17.s0.e3" id="DS1.d17.s0.i0" interaction="True" />
            <pair e1="DS1.d17.s0.e1" e2="DS1.d17.s0.e3" id="DS1.d17.s0.i1" interaction="True" />
            <pair e1="DS1.d17.s0.e2" e2="DS1.d17.s0.e3" id="DS1.d17.s0.i2" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d18" origId="17950491">
        <sentence id="DS1.d18.s0" origId="17950491-1124" text="In this study the PPAR gamma agonist, rosiglitazone, was orally administered to young and aged rats, and we report that the age-related increases in NO and IL-1 beta production were attenuated in hippocampus of rosiglitazone-treated aged rats and that this was associated with a restoration of LTP.">
            <entity id="DS1.d18.s0.e0" origId="77999" charOffset="38-51" type="compound" text="rosiglitazone"/>
            <entity id="DS1.d18.s0.e1" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="156-165" type="protein" text="IL-1 beta"/>
            <entity id="DS1.d18.s0.e2" origId="77999" charOffset="211-224" type="compound" text="rosiglitazone"/>
            <pair e1="DS1.d18.s0.e0" e2="DS1.d18.s0.e1" id="DS1.d18.s0.i0" interaction="True" />
        </sentence>
        <sentence id="DS1.d18.s1" origId="17950491-1125" text="In addition, treatment with rosiglitazone  increased interleukin-4 (IL-4) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.">
            <entity id="DS1.d18.s1.e0" origId="77999" charOffset="28-41" type="compound" text="rosiglitazone"/>
            <entity id="DS1.d18.s1.e1" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="68-72" type="protein" text="IL-4"/>
            <entity id="DS1.d18.s1.e2" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="132-136" type="protein" text="IL-4"/>
            <pair e1="DS1.d18.s1.e0" e2="DS1.d18.s1.e1" id="DS1.d18.s1.i0" interaction="True" />
        </sentence>
        <sentence id="DS1.d18.s2" origId="17950491-1126" text="Significantly, while rosiglitazone attenuated the LPS-induced increase in MHCII and IL-1 beta concentration in glia prepared from wildtype mice, it failed to exert an effect in glia prepared from IL-4 (-/-) mice, thereby suggesting that the anti-inflammatory actions of rosiglitazone are mediated by its ability to increase IL-4 expression.">
            <entity id="DS1.d18.s2.e0" origId="77999" charOffset="21-34" type="compound" text="rosiglitazone"/>
            <entity id="DS1.d18.s2.e1" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="84-93" type="protein" text="IL-1 beta"/>
            <entity id="DS1.d18.s2.e2" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="196-200" type="protein" text="IL-4"/>
            <entity id="DS1.d18.s2.e3" origId="77999" charOffset="270-283" type="compound" text="rosiglitazone"/>
            <entity id="DS1.d18.s2.e4" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="324-328" type="protein" text="IL-4"/>
            <pair e1="DS1.d18.s2.e0" e2="DS1.d18.s2.e1" id="DS1.d18.s2.i0" interaction="True" />
            <pair e1="DS1.d18.s2.e0" e2="DS1.d18.s2.e2" id="DS1.d18.s2.i1" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d19" origId="17965987">
        <sentence id="DS1.d19.s0" origId="17965987-548" text="Serum BDNF  levels were increased and plasma levels of HVA and MHPG were decreased according to the recovery from the active phase of the disease.">
            <entity id="DS1.d19.s0.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="6-10" type="protein" text="BDNF"/>
            <entity id="DS1.d19.s0.e1" origId="1738" charOffset="55-58" type="compound" text="HVA"/>
            <entity id="DS1.d19.s0.e2" origId="10805" charOffset="63-67" type="compound" text="MHPG"/>
            <pair e1="DS1.d19.s0.e1" e2="DS1.d19.s0.e0" id="DS1.d19.s0.i0" interaction="False" />
            <pair e1="DS1.d19.s0.e2" e2="DS1.d19.s0.e0" id="DS1.d19.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS1.d19.s1" origId="17965987-549" text="These results suggest that dysfunctions of catecholaminergic neurons and neurotrophic factors might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to risperidone might be associated with the improvement of the disease.">
            <entity id="DS1.d19.s1.e0" origId="P18280,P20181,P20783,P25433,P25434,P25435,Q9TST2" charOffset="73-93" type="protein" text="neurotrophic factors"/>
            <entity id="DS1.d19.s1.e1" origId="5073" charOffset="187-198" type="compound" text="risperidone"/>
            <pair e1="DS1.d19.s1.e1" e2="DS1.d19.s1.e0" id="DS1.d19.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS1.d20" origId="17968352">
        <sentence id="DS1.d20.s0" origId="17968352-738" text="Based on these validities we identified alterations in the Wolframin gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with citalopram.">
            <entity id="DS1.d20.s0.e0" origId="O76024,P56695" charOffset="59-68" type="protein" text="Wolframin"/>
            <entity id="DS1.d20.s0.e1" origId="2771,146570" charOffset="190-200" type="compound" text="citalopram"/>
            <pair e1="DS1.d20.s0.e1" e2="DS1.d20.s0.e0" id="DS1.d20.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d21" origId="17968676">
        <sentence id="DS1.d21.s0" origId="17968676-960" text="Cyclooxygenase-2 (Cox-2) is a key enzyme in the conversion of arachidonic acid to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).">
            <entity id="DS1.d21.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="0-16" type="protein" text="Cyclooxygenase-2"/>
            <entity id="DS1.d21.s0.e1" origId="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9" charOffset="18-23" type="protein" text="Cox-2"/>
            <entity id="DS1.d21.s0.e2" origId="444899" charOffset="62-78" type="compound" text="arachidonic acid"/>
            <pair e1="DS1.d21.s0.e2" e2="DS1.d21.s0.e0" id="DS1.d21.s0.i0" interaction="True" />
            <pair e1="DS1.d21.s0.e2" e2="DS1.d21.s0.e1" id="DS1.d21.s0.i1" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d22" origId="17976762">
        <sentence id="DS1.d22.s0" origId="17976762-900" text="Other potential treatments discussed for possible use with long-acting insulin overdoses include incision and drainage of the injection site, glucagon, and octreotide.">
            <entity id="DS1.d22.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="71-78" type="protein" text="insulin"/>
            <entity id="DS1.d22.s0.e1" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="142-150" type="protein" text="glucagon"/>
            <entity id="DS1.d22.s0.e2" origId="383414,448601" charOffset="156-166" type="compound" text="octreotide"/>
            <pair e1="DS1.d22.s0.e2" e2="DS1.d22.s0.e0" id="DS1.d22.s0.i0" interaction="False" />
            <pair e1="DS1.d22.s0.e2" e2="DS1.d22.s0.e1" id="DS1.d22.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS1.d23" origId="18037312">
        <sentence id="DS1.d23.s0" origId="18037312-328" text="Cadmium inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in MMP-9 activity in the BALF.">
            <entity id="DS1.d23.s0.e0" origId="23973" charOffset="0-7" type="compound" text="Cadmium"/>
            <entity id="DS1.d23.s0.e1" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="242-247" type="protein" text="MMP-9"/>
            <pair e1="DS1.d23.s0.e0" e2="DS1.d23.s0.e1" id="DS1.d23.s0.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d24" origId="18042181">
        <sentence id="DS1.d24.s0" origId="18042181-810" text="Intracellular  GSH content is maintained by de novo synthesis, involving glutamate-cysteine ligase catalytic (GCLC) and modulatory (GCLM) subunits, and by recycling from oxidized  GSH, catalysed by glutathione reductase (GR).">
            <entity id="DS1.d24.s0.e0" origId="124886" charOffset="15-18" type="compound" text="GSH"/>
            <entity id="DS1.d24.s0.e1" origId="P48506" charOffset="110-114" type="protein" text="GCLC"/>
            <entity id="DS1.d24.s0.e2" origId="P48507,Q2T9Y6" charOffset="132-136" type="protein" text="GCLM"/>
            <entity id="DS1.d24.s0.e3" origId="124886" charOffset="180-183" type="compound" text="GSH"/>
            <entity id="DS1.d24.s0.e4" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="198-219" type="protein" text="glutathione reductase"/>
            <pair e1="DS1.d24.s0.e0" e2="DS1.d24.s0.e2" id="DS1.d24.s0.i0" interaction="True" />
            <pair e1="DS1.d24.s0.e0" e2="DS1.d24.s0.e4" id="DS1.d24.s0.i1" interaction="True" />
            <pair e1="DS1.d24.s0.e0" e2="DS1.d24.s0.e1" id="DS1.d24.s0.i2" interaction="True" />
        </sentence>
        <sentence id="DS1.d24.s1" origId="18042181-811" text="To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate  GSH production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.">
            <entity id="DS1.d24.s1.e0" origId="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487" charOffset="57-87" type="protein" text="basic fibroblast growth factor"/>
            <entity id="DS1.d24.s1.e1" origId="124886" charOffset="105-108" type="compound" text="GSH"/>
            <entity id="DS1.d24.s1.e2" origId="P48506" charOffset="169-173" type="protein" text="GCLC"/>
            <entity id="DS1.d24.s1.e3" origId="P48507,Q2T9Y6" charOffset="175-179" type="protein" text="GCLM"/>
            <pair e1="DS1.d24.s1.e1" e2="DS1.d24.s1.e3" id="DS1.d24.s1.i0" interaction="True" />
            <pair e1="DS1.d24.s1.e1" e2="DS1.d24.s1.e0" id="DS1.d24.s1.i1" interaction="True" />
            <pair e1="DS1.d24.s1.e1" e2="DS1.d24.s1.e2" id="DS1.d24.s1.i2" interaction="True" />
        </sentence>
        <sentence id="DS1.d24.s2" origId="18042181-812" text="In conclusion, our results show that FSH and bFGF increase GSH  levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating  GCLM and GR expression respectively.">
            <entity id="DS1.d24.s2.e0" origId="124886" charOffset="59-62" type="compound" text="GSH"/>
            <entity id="DS1.d24.s2.e1" origId="P48507,Q2T9Y6" charOffset="164-168" type="protein" text="GCLM"/>
            <pair e1="DS1.d24.s2.e0" e2="DS1.d24.s2.e1" id="DS1.d24.s2.i0" interaction="True" />
        </sentence>
    </document>
    <document id="DS1.d25" origId="18061671">
        <sentence id="DS1.d25.s0" origId="18061671-210" text="Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.">
            <entity id="DS1.d25.s0.e0" origId="54670067,54690394" charOffset="132-145" type="compound" text="ascorbic acid"/>
            <entity id="DS1.d25.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="147-155" type="protein" text="catalase"/>
            <entity id="DS1.d25.s0.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="157-160" type="protein" text="CAT"/>
            <entity id="DS1.d25.s0.e3" origId="614,8988,145742" charOffset="246-253" type="compound" text="proline"/>
            <entity id="DS1.d25.s0.e4" origId="O50258" charOffset="264-284" type="protein" text="superoxide dismutase"/>
            <entity id="DS1.d25.s0.e5" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="286-289" type="protein" text="SOD"/>
            <entity id="DS1.d25.s0.e6" origId="P15984,P16147,P84714" charOffset="295-305" type="protein" text="peroxidase"/>
            <entity id="DS1.d25.s0.e7" origId="P59097,P79076,Q5B2E9,Q5G234,Q6QWR1,Q6UG02,Q75ZP8,Q8J136,Q8J2V8" charOffset="307-310" type="protein" text="POD"/>
            <entity id="DS1.d25.s0.e8" origId="P22079,P80025" charOffset="328-331" type="protein" text="LPO"/>
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e6" id="DS1.d25.s0.i0" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e6" id="DS1.d25.s0.i1" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e2" id="DS1.d25.s0.i2" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e1" id="DS1.d25.s0.i3" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e5" id="DS1.d25.s0.i4" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e7" id="DS1.d25.s0.i5" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e2" id="DS1.d25.s0.i6" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e5" id="DS1.d25.s0.i7" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e8" id="DS1.d25.s0.i8" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e4" id="DS1.d25.s0.i9" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e7" id="DS1.d25.s0.i10" interaction="False" />
            <pair e1="DS1.d25.s0.e3" e2="DS1.d25.s0.e1" id="DS1.d25.s0.i11" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e8" id="DS1.d25.s0.i12" interaction="False" />
            <pair e1="DS1.d25.s0.e0" e2="DS1.d25.s0.e4" id="DS1.d25.s0.i13" interaction="False" />
        </sentence>
</document>
</corpus>
